Retinal Reports

2017 Ophthalmic Laser Report: A Global Market Analysis for 2016 to 2022 (Photocoagulation, Photodisruption, and SLT

Our report on the ophthalmic laser market is in its seventh edition. It is a leading industry source for accurate and relevant information on all aspects of the market. The report discusses the epidemiology of retinal diseases, glaucoma, and cataracts, plus other diseases and disorders that require laser intervention. The report covers photocoagulation, photodisruption, and SLT lasers. It excludes excimer and femtosecond lasers. We forecast product demand in units and dollars, and we analyze market shares by product category.

Additional DescriptionMore Details

We analyze worldwide markets using the following geographic/economic categories: the US, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America, and Rest of World. This report includes market data for 2016, and we forecast market performance through 2022.

ABOUT THE AUTHOR

Our report is organized into key areas and includes:

• Review of Global Retinal Diseases and Treatment Methods
• Review of Global Glaucoma and Treatment Methods
• Review of Global Cataracts and Treatment Methods
• Global Overview of Ophthalmologists
• Forecast of Photocoagulation Lasers by Region
• Forecast of Photodisruption Lasers by Region
• Forecast of SLT Lasers by Region
• 13 Company Profiles
• 50 Color Tables and 22 Color Figures

2017 Laser Report Graphic

The data included in our reports is based on surveys of ophthalmologists, reviews of clinical data, interviews with company executives, published medical reviews, and analysis of company financial data.

VIEW THE TABLE OF CONTENTS OF THIS REPORT

This edition of our Ophthalmic Laser Report: A Global Market Analysis for 2016 to 2022 was released in June 2017. The report is printed in color and spiral bound for easy reading. Two licensing types are available for this report. The price of the report is $4,000 for a SINGLE USER LICENSE (an electronic PDF copy and/or an additional paper copy is available for use within your company for an additional $500 and $300, respectively). The price of the ENTERPRISE LICENSE is $6,000 (includes a printable PDF and supplemental Excel file with all the tables and figures in the report).

*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.

Market Scope’s industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective ophthalmic experience and each data point is driven by a combination of sources, including the following:

• Our proprietary global disease population and demographic models
• Twenty years and counting of ophthalmologist survey data
• Analysis of company published financial reports
• Focused coverage of ophthalmic scientific research, business news and other activities
• Attendance and participation in major, worldwide ophthalmic meetings
• Interviews and long-standing relationships with company executives and practicing ophthalmologists

Product Options

Price: from $4,000.00

Loading Updating cart...

2017 Retinal Surgical Devices Report: A Global Market Analysis for 2016 to 2022

Our report on the retinal surgical device market is in its 14th edition, and it is the leading industry source for accurate and relevant information on all aspects of the global retinal surgical device market. We cover prevalence and forecasts for retinal diseases and conditions. We discuss therapeutic approaches and describe both commercialized products and products in the pipeline. We analyze unit demand and revenue and forecast future performance over the next five years. We also include market share data and discuss key strategic issues.

Additional DescriptionMore Details

What’s new: Retina care is evolving rapidly with many countervailing trends. Soaring elderly population share, improving equipment and surgical techniques, and improved access to advanced medical care are combining to create new opportunities in this market. However, increased access to anti-VEGF treatments and vitreolytics promises to stave off the need for vitrectomies through earlier treatments.

In our comprehensive reports, we analyze worldwide markets using the following geographic/economic categories: the US, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America, and Rest of World. This report includes market data for 2016, and we forecast market performance through 2022.

Market Scope’s 2017 Retinal Surgical Devices Report: A Global Market Analysis for 2016 to 2022 provides in-depth coverage of the equipment and devices used in retinal surgical procedures.

ABOUT THE AUTHOR

Our report is organized into key areas and includes:

Review of Retinal Physiology, Diseases, and Procedures
Prevalence Data
Patient Economics and Reimbursement
Retinal Specialists and Societies
Vitrectomy Machines and Machine Packs
Hemostatic Devices
Cryosurgical Systems
Light-Source Consoles and Illuminator Probes
Scleral Buckles, Silicone Oil, and Ocular Gases
Retinal Surgical Instruments
Photocoagulation Lasers
Single-Use Retinal Surgical Products
Implantable Telescopic IOLs
Artificial Vision Technologies
Five-Year Forecasts for Market Performance
54 Company Profiles
85 Color Tables and 65 Color Figures

2017 Retinal Surgical Device Chart


The data included in our reports is based on surveys of retina specialists, reviews of clinical data, interviews with company executives, and analysis of company financial data.

This edition of our 2017 Retinal Surgical Devices Report: A Global Market Analysis for 2016 to 2022 was released in April 2017. The report is printed in color and spiral bound for easy reading. Two licensing types are available for this report. The price of the report is $5,750 for a SINGLE USER LICENSE (an electronic PDF copy and/or an additional paper copy is available for use within your company for an additional $500 and $300, respectively). The price of the ENTERPRISE LICENSE is $8,625 (includes a printable PDF and supplemental Excel file with all the tables and figures in the report).

VIEW THE TABLE OF CONTENTS FOR THIS REPORT

*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.

Product Options

Price: from $5,750.00

Loading Updating cart...

2016 Retinal Pharmaceuticals and Biologics Report: A Global Market Analysis for 2015 to 2021

Our report on the retinal pharmaceuticals and biologics market is in its seventh edition. It is a leading industry source for accurate and relevant information on all aspects of the market. We cover prevalence and forecasts for retinal diseases and conditions. We discuss therapeutic approaches and mechanisms of action under investigation. We discuss the market dynamics for currently commercialized products and the rich and crowded pipeline of investigational therapies. We review patient-based economic issues and reimbursement and analyze treatment patterns and trends. We also forecast product demand in units and dollars, and we analyze market shares by product category.

Additional DescriptionMore Details

We analyze worldwide markets using the following geographic/economic categories: the US, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America and Rest of World. This report includes market data for 2015, and we forecast market performance through 2021.

Market Scope’s 2016 Retinal Pharmaceuticals and Biologics Report provides in-depth coverage of current and future pharmaceuticals and biologics used in treating retinal diseases.

ABOUT THE AUTHOR

Our report is organized into key areas and includes:

Review of Retinal Diseases and Treatments
Symptoms, Diagnosis and Treatment of AMD
Diagnosis and Management of Diabetic Retinopathy and Macular Edema
An Overview of Other Retinal Diseases and Conditions
Epidemiology of Retinal Disease
Patient Economics and Reimbursement
Retina Specialists and Training
Current Retinal Pharmaceuticals in the Marketplace
Mechanisms of Action for Current and Future Therapies
Five-Year Forecast for the Global Retinal Pharmaceutical Market by Region
28 Company Profiles and Additional Company Listings
46 Color Tables and 43 Color Figures

The data included in our reports is based on surveys of retina specialists, reviews of clinical data, interviews with company executives and analysis of company financial data.

VIEW THE TABLE OF CONTENTS FOR THIS REPORT

This edition of our 2016 Retinal Pharmaceuticals and Biologics Report: A Global Market Analysis for 2015 to 2021 will be released in early November. The report is printed in color and spiral bound for easy reading. Two licensing types are available for this report. The price of the report is $6,250 for a SINGLE USER LICENSE (an electronic PDF copy and/or an additional paper copy is available for use within your company for an additional $500 and $300, respectively). The price of the ENTERPRISE LICENSE is $ 9,375 (includes a printable PDF and supplemental Excel file with all the tables and figures in the report).

*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.

Product Options

Price: from $6,250.00

Loading Updating cart...

US Retinal Market Quarterly Updates

Our US Retinal Market Quarterly Updates are designed to keep you up to date with data gathered four times per year on the practice of retinal medicine, both pharmaceutical and surgical. We began this survey process in 2008. These updates are designed to improve your decision-making process with accurate and timely information on a variety of vital practice of medicine issues, doctors’ evaluations of pharmaceuticals and surgical equipment, and the identification of significant trends in the marketplace for  retinal pharmaceuticals and devices.

Additional DescriptionMore Details

Our updates include trend analysis based on comparisons with information gathered in previous years. All information is presented in color charts and tables with concise narratives for enhanced clarity and context.

We measure and analyze the key metrics of the US retina treatments market, including the following topics:

Use of Lucentis, Avastin, and Eylea
IVT Injections
DME Treatments
Corticosteroid Use
Photocoagulation Volume and Photocoagulators Used
Use of Jetrea
Vitrectomy Volume and Location
Disposable Procedure Packs
Reusable and Disposable Instruments

2012 Retina Quarterly Update Image

We also provide a full-year forecast for US retinal procedures (including IVT injections) and a comparison with volumes during the prior year. The survey has been developed in conjunction with retina specialists and industry manufacturers.

Our US Retina Quarterly Market Updates are published each quarter. We have been conducting surveys of ophthalmologists in various subspecialties for 12 years, and our analyses of survey data are used by hundreds of ophthalmological practices and businesses in the ophthalmic industry. Each update can be purchased separately for $3,000, or an annual subscription is available for $10,750.

*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.

VIEW THE TABLE OF CONTENTS FOR THIS REPORT

Product Options

Price: from $4,000.00

Loading Updating cart...
LoadingUpdating...

Shopping Cart

Your shopping cart is empty
View all of the reports

Note: Report PDFs are not downloadable

PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.